Correlation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and D-dimer with remission time of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia

Li LAI; Zhuoying HU

doi:10.16016/j.1000-5404.202106028

您当前的位置：

首页 >

文章列表页 >

Correlation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and D-dimer with remission time of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia

Clinical Medicine | 更新时间：2026-01-09

- Correlation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and D-dimer with remission time of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia
- Journal of Third Military Medical University Vol. 43, Issue 23, Pages: 2596-封3(2021)
- 作者机构：
  
  400016 重庆，重庆医科大学附属第一医院妇科
- 作者简介：
- 基金信息：
- DOI：10.16016/j.1000-5404.202106028
  CLC： R446.11;R730.7;R737.33
- Received：03 June 2021，
  
  Revised：2021-07-15，
  
  Published：15 December 2021
- 稿件说明：
移动端阅览
Li LAI, Zhuoying HU. Correlation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and D-dimer with remission time of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia[J]. Journal of Third Military Medical University, 2021, 43(23): 2596-封3.
DOI：

Li LAI, Zhuoying HU. Correlation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and D-dimer with remission time of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia[J]. Journal of Third Military Medical University, 2021, 43(23): 2596-封3. DOI： 10.16016/j.1000-5404.202106028.

摘要

目的

研究治疗前中性粒细胞与淋巴细胞比值(neutrophil to lymphocyte ratio，NLR)、淋巴细胞与血小板比值(platelet to lymphocyte ratio，PLR)、D-二聚体及临床因素与妊娠滋养细胞肿瘤(gestational trophoblastic neoplasia，GTN)患者血人绒毛膜促性腺激素(human chorionic gonadotropin，hCG)转阴时间的相关性。

方法

选取本院2011年2月至2020年12月收治的绒毛膜癌及侵袭性葡萄胎患者共97例进行回顾性分析，平均年龄34岁，单因素及多因素分析患者年龄、前次妊娠性质、距前次妊娠终止时间、肿瘤分期、FIGO评分、化疗方案、治疗前hCG、NLR、PLR及D-二聚体与血hCG转阴时间的关系。

结果

患者hCG中位转阴时间为64 d

妊娠性质、距妊娠终止时间、FIGO评分、化疗方案、治疗前hCG、NLR、PLR及D-二聚体与hCG转阴时间相关(

0.05)，多因素分析结果显示FIGO评分高危(

=12.368)、极高危(

=4.205)，hCG≥10 000 IU/L(

=2.582)，NLR≥2.29(

=1.675)，EMA-CO方案(

=6.183)及MTX转EMA-CO方案(

=4.472)是延长转阴时间的危险因素，对EMA-CO组进行亚组分析，发现FIGO评分高危(

=7.759)、极高危(

=3.633)，hCG≥10 000 IU/L(

=2.535)，NLR≥2.29(

=2.29)是延长该亚组hCG转阴时间的独立危险因素。

结论

NLR与GTN患者血hCG转阴时间相关，治疗前NLR越高，GTN患者血hCG转阴时间越长。

Abstract

Objective

To investigate the correlation of pre-treatment neutrophil-to-lymphocyte ratio (NLR)

platelet-to-lymphocyte ratio (PLR)

D-dimer level and other clinical factors with the time to serum human chorionic gonadotropin (hCG) remission in patients with gestational trophoblastic neoplasia (GTN).

Methods

A total of 97 patients (mean age: 34 years) with GTN admitted to our hospital from February 2011 to December 2020 were enrolled and their clinical data were retrospectively analyzed. Univariate and multivariate analyses were performed to investigate the correlation between hCG remission time with factors such as age

antecedent pregnancy

interval time from previous pregnancy

tumor stage

FIGO score

chemotherapy regimen

serum hCG level

NLR

PLR and D-dimer before treatment.

Results

Among the included patients

the median time to hCG remission was 64 d. The antecedent pregnancy

inter

val time from previous pregnancy

FIGO score

chemotherapy regimen

pre-treatment hCG level

NLR

PLR and D-dimer were all proved to be correlated with hCG remission time (

0.05). Multivariate analysis confirmed that high-risk FIGO score (

=12.368)

extremely high-risk FIGO score (

=4.205)

hCG level ≥10 000 IU/L (

=2.582)

NLR≥2.29 (

=1.675)

chemotherapy with EMA-CO regimen (

=6.183) and changing MTX regimen to EMA-CO regimen (

=4.472) were independent risk factors for extended time to hCG remission. Subgroup analysis on the patients with initial EMA-CO regimen revealed that high-risk FIGO score (

=7.759)

extremely high-risk FIGO score (

=3.633)

pre-treatment hCG≥10 000 IU/L (

=2.535) and NLR≥2.29 (

=2.29) were also the independent risk factors for extended hCG remission time in this group.

Conclusion

NLR is related to the remission time for hCG in GTN patients. The higher pre-treatment hCG is

the longer hCG remission time.

关键词

Keywords

references

AZNAB M, NANKALI A, DAEICHIN S. Determination of clinical process and response rate to treatment in patients with gestational trophoblastic neoplasia (GTN) with low and high risk and evaluation of their first pregnancy outcome[J]. Int J Hematol Oncol Stem Cell Res, 2018, 12(4): 291-297.

BATTI R, MOKRANI A, RACHDI H, et al . Gestational trophoblastic neoplasia: experience at Salah Azaiez Institute[J ] . Pan Afr Med J, 2019, 33: 121. DOI: 10.11604/pamj.2019.33.121.13897.

BRAGA A, MORA P, DE MELO A C, et al . Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide[J ] . World J Clin Oncol, 2019, 10(2): 28-37. DOI: 10.5306/wjco.v10.i2.28.

WU L, SAXENA S, SINGH R K. Neutrophils in the tumor microenvironment[J]. Adv Exp Med Biol, 2020, 1224: 1-20. DOI: 10.1007/978-3-030-35723-8_1.

LI Z, HONG N, ROBERTSON M, et al . Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancer[J ] . Sci Rep, 2017, 7: 43001. DOI: 10.1038/srep43001.

VAHID DASTJERDI M, AHMARI S, ALIPOUR S, et al . The comparison of plasma D-dimer levels in benign and malignant tumors of cervix, ovary and uterus[J ] . Int J Hematol Oncol Stem Cell Res, 2015, 9(3): 107-111.

YANG L, DONG H, LI Z, et al . Correlation between circulating tumor cells and D-D and platelet in patients with pulmonary malignancies[J ] . Oncol Lett, 2018, 15(2): 2169-2172. DOI: 10.3892/ol.2017.7595.

XU L, HE F, WANG H, et al . A high plasma D-dimer level predicts poor prognosis in gynecological tumors in East Asia area: a systematic review and meta-analysis[J ] . Oncotarget, 2017, 8(31): 51551-51558. DOI: 10.18632/oncotarget.17936.

SOPER J T. Gestational trophoblastic disease: current evaluation and management[J]. Obstet Gynecol, 2021, 137(2): 355-370. DOI: 10.1097/aog.0000000000004240.

SUPRASERT P, SIRIAREE S, MANOPUNYA M. Outcomes of metastatic gestational trophoblastic neoplasia: fourteen year experience from a northern Thailand tertiary care center[J]. Asian Pac J Cancer Prev, 2016, 17(3): 1357-1362. DOI: 10.7314/apjcp.2016.17.3.1357.

BANACH P, ZABOROWSKI M P, IZYCKA N, et al . The value of an initial drop in human Chorionic gonadotropin levels in predicting a response to methotrexate in women with low-risk gestational trophoblastic neoplasia[J ] . Ginekologia Polska, 2019, 90(3): 141-147. DOI: 10.5603/GP.2019.0025.

IBETO L, ANTONOPOULOS A, GRASSI P, et al . Insights into the hyperglycosylation of human chorionic gonadotropin revealed by glycomics analysis[J ] . PLoS ONE, 2020, 15(2): e0228507. DOI: 10.1371/journal.pone.0228507.

LI M, SPAKOWICZ D, BURKART J, et al . Change in neutrophi l to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers[J ] . J Cancer Res Clin Oncol, 2019, 145(10): 2541-2546.DOI: 10.1007/s00432-019-02982-4.

SECKIN K D, KARSLı M F, YUCEL B, et al . The utility of tumor markers and neutrophil lymphocyte ratio in patients with an intraoperative diagnosis of mucinous borderline ovarian tumor[J ] . Eur J Obstet Gynecol Reprod Biol, 2016, 196: 60-63. DOI: 10.1016/j.ejogrb.2015.10.025.

GUZEL A I, KOKANALI M K, ERKILINC S, et al . Predictive role of the neutrophil lymphocyte ratio for invasion with gestational trophoblastic disease[J ] . Asian Pac J Cancer Prev, 2014, 15(10): 4203-4206. DOI: 10.7314/apjcp.2014.15.10.4203.

SHAUL M E, FRIDLENDER Z G. Cancer-related circulating and tumor-associated neutrophils-subtypes, sources and function[J]. Febs J, 2018, 285(23): 4316-4342. DOI: 10.1111/febs.14524.

MUKAIDA N, SASAKI S I, BABA T. Two-faced roles of tumor-associated neutrophils in cancer development and progression[J]. Int J Mol Sci, 2020, 21(10): 3457. DOI: 10.3390/ijms21103457.

VERAS E, KURMAN R J, WANG T L, et al . PD-L1 expression in human placentas and gestational trophoblastic diseases[J ] . Int J Gynecol Pathol, 2017, 36(2): 146-153. DOI: 10.1097/pgp.0000000000000305.

MAGNUS N, GARNIER D, MEEHAN B, et al . Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations[J ] . Proc Natl Acad Sci USA, 2014, 111(9): 3544-3549. DOI: 10.1073/pnas.1314118111.

YU J, LI D, LEI D, et al . Tumor-specific D-dimer concentration ranges and influencing factors: a cross-sectional study[J ] . PLoS ONE, 2016, 11(11): e0165390. DOI: 10.1371/journal.pone.0165390.

朱烨, 周璘, 雷月, 等. 低危型妊娠滋养细胞肿瘤血β-HCG下降时间的影响因素分析[J]. 实用妇产科杂志, 2016, 32(11): 834-838.

ZHU Y, ZHOU L, LEI Y, et al . Prognostic factors associated with HCG regression time in postmolar gestational trophoblastic neoplasia patients[J ] . J Prac Obste Gynecol, 2016, 32(11): 834-838.

胡静. 妊娠滋养细胞肿瘤血hCG转阴时间的相关因素分析[D]. 重庆: 重庆医科大学, 2020.

HU J. Clinical factors associated with time to HCG remission in patients with gestational trophoblastic neoplasia[D]. Chongqing: Chongqing Medical University, 2020.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Correlation between peripheral blood inflammatory factors and quality of life in patients with atrial fibrillation

Predictive value of preoperative D-dimer combined with activated partial thromboplastin time for slow/no-reflow phenomenon in emergency percutaneous coronary intervention

Application value of combined detection of D-dimer and fibrinogen in diagnosis of deep venous thrombosis

Related Author

李亚斐

钟理

张志辉

吴龙

李成英

贾潇岳

向颖

陈兴华

Related Institution

No data

⁰